Cenobamate manufacturers

This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

This company specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, focusing on cost-effective solutions with a strong emphasis on quality. They offer contract development and manufacturing services (CDMO) for both New Chemical Entities (NCEs) and APIs, leveraging their globally compliant GMP facilities and expertise in modified release technologies. The company boasts state-of-the-art production lines capable of handling high-potent materials across various scales, catering to a wide range of pharmaceutical products including prescription medications and potentially over-the-counter drugs. While specific therapy areas aren't mentioned, they hold patents for their innovations and are actively involved in research and development. Their operations span multiple regions, including North America and the EU.

This pharmaceutical company specializes in developing and supplying drug products and substances to global markets. Their focus is on innovation and quality, offering both prescription and over-the-counter products. The company boasts strong GMP certifications, ensuring adherence to international standards. Their portfolio likely includes solid dosage forms and may extend to injectables or liquids. While specific therapy areas are not mentioned, the focus on advanced markets suggests specialization in areas like oncology, cardiology, or neurology. With a proven track record of supplying high-quality pharmaceuticals, they likely hold multiple product patents. The company's decades-long presence in the industry, particularly in the European Union and North America, underscores their commitment to global healthcare solutions.